These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3498790)

  • 21. A molecular hybrid of the H-2Dd and H-2Ld genes expressed in the dm1 mutant.
    Burnside SS; Hunt P; Ozato K; Sears DW
    Proc Natl Acad Sci U S A; 1984 Aug; 81(16):5204-8. PubMed ID: 6206494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein.
    Takahashi H; Houghten R; Putney SD; Margulies DH; Moss B; Germain RN; Berzofsky JA
    J Exp Med; 1989 Dec; 170(6):2023-35. PubMed ID: 2479705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a murine mutant Ras CD8+ CTL peptide epitope variant that possesses enhanced MHC class I binding and immunogenic properties.
    Bristol JA; Schlom J; Abrams SI
    J Immunol; 1998 Mar; 160(5):2433-41. PubMed ID: 9498787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An H-2Ld hybrid molecule with a Qa-2 alpha-3 domain and phosphatidyl-inositol anchor is not recognized by H-2Ld-specific cytotoxic T lymphocytes.
    Mann DW; Stroynowski I; Hood L; Forman J
    J Immunol; 1989 Jan; 142(1):318-22. PubMed ID: 2462590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatic cell variants express altered H-2Kb allodeterminants recognized by cytolytic T cell clones.
    Bluestone JA; Langlet C; Geier SS; Nathenson SG; Foo M; Schmitt-Verhulst AM
    J Immunol; 1986 Aug; 137(4):1244-50. PubMed ID: 2426358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybrid H-2 histocompatibility gene products assign domains recognized by alloreactive T cells.
    Ozato K; Evans GA; Shykind B; Margulies DH; Seidman JG
    Proc Natl Acad Sci U S A; 1983 Apr; 80(7):2040-3. PubMed ID: 6188160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatic H-2Kk variants reveal nonidentity of serological and cytotoxic T cell-defined Kk determinants.
    Vohr HW; Holtkamp B; Rajewsky K
    Eur J Immunol; 1983 Oct; 13(10):846-51. PubMed ID: 6196205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The alpha-3 domain of class I MHC proteins influences cytotoxic T lymphocyte recognition of antigenic determinants located within the alpha-1 and alpha-2 domains.
    Maziarz RT; Burakoff SJ; Bluestone JA
    J Immunol; 1988 Jun; 140(12):4372-7. PubMed ID: 2453580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of mutant H-2d proteins encoded by class I genes which alternatively process the 5' end of their transcripts.
    Hedley ML; Ozato K; Maryanski J; Tucker PW; Forman J
    J Immunol; 1989 Aug; 143(3):1026-31. PubMed ID: 2473108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
    Shirai M; Pendleton CD; Berzofsky JA
    J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatic cell variants of H-2Kb: a point mutation in the first extracellular domain results in altered immune recognition.
    Nakagawa M; Zeff RA; Geier SS; Bluestone JA; Nathenson SG
    Immunogenetics; 1986; 24(6):381-5. PubMed ID: 3491786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic T lymphocytes (CTL) against a transforming gene product select for transformed cells with point mutations within sequences encoding CTL recognition epitopes.
    Lill NL; Tevethia MJ; Hendrickson WG; Tevethia SS
    J Exp Med; 1992 Aug; 176(2):449-57. PubMed ID: 1380062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of alpha3 domain of class I MHC molecules in the activation of high- and low-avidity CD8+ CTLs.
    Belyakov IM; Kozlowski S; Mage M; Ahlers JD; Boyd LF; Margulies DH; Berzofsky JA
    Int Immunol; 2007 Dec; 19(12):1413-20. PubMed ID: 17981793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different effects of substitutions at residues 224 and 228 of MHC class I on the recognition of CD8.
    Sekimata M; Tanabe M; Sarai A; Yamamoto J; Kariyone A; Nakauchi H; Egawa K; Takiguchi M
    J Immunol; 1993 May; 150(10):4416-26. PubMed ID: 8482843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db-mutant) mice. II. Relationship of Kbm3 and Kbm11 in restriction specificities and allodeterminants.
    Stukart MJ; Boes J; Melief CJ
    J Immunol; 1984 Jul; 133(1):28-32. PubMed ID: 6202783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis of Kbm8 alloreactivity. Amino acid substitutions on the beta-pleated floor of the antigen recognition site.
    Hunt HD; Pullen JK; Dick RF; Bluestone JA; Pease LR
    J Immunol; 1990 Sep; 145(5):1456-62. PubMed ID: 2384667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of point mutations in the native simian virus 40 tumor antigen, and in synthetic peptides corresponding to the H-2Db-restricted epitopes, on antigen presentation and recognition by cytotoxic T lymphocyte clones.
    Deckhut AM; Tevethia SS
    J Immunol; 1992 May; 148(10):3012-20. PubMed ID: 1374447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired MHC class I (H-2Dd)-mediated protection against Ly-49A+ NK cells after amino acid substitutions in the antigen binding cleft.
    Waldenström M; Sundbäck J; Olsson-Alheim MY; Achour A; Kärre K
    Eur J Immunol; 1998 Sep; 28(9):2872-81. PubMed ID: 9754574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
    Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
    Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.